What this research found
Kidney Cancer - What Sets the Subtypes Apart
Archived study
Compares expression and pathway patterns in 39 historical renal tumors: 22 clear-cell, 11 papillary and six chromophobe samples. The analysis supports higher hypoxia-related expression in clear-cell tumors and higher oxidative-phosphorylation expression in chromophobe tumors. Pathway counts surviving all stated sensitivity checks were 1, 16 and 7 across the three subtype contrasts.
Interpretation and limits
The small, historical bulk-tissue cohort lacks independently reassessed pathology, patient linkage, batch, purity and treatment information. Pathway scores summarize relative expression rather than biochemical activity. Reused-sample sensitivity checks do not establish causal mechanisms, diagnostic accuracy or clinical biomarkers.
Package and provenance
The unchanged research package comes from the upstream archive. It retains the original conversation and included scientific artifacts, including analysis code, results and figures. The poster is an AI-generated thematic illustration, not study evidence. This introduction summarizes archived findings; the analysis was not rerun. Later bounded checks do not certify the entire study or mean the original package was corrected.
Import provenance
This case was added to the Academic Research category on 2026-10-13, with the archived upstream case recorded as its source. The supplied session export and poster were uploaded without changing their contents. This introduction summarizes the archived findings and was standardized for the repository. The study, external data sources, and scientific results were not rerun or independently reverified for this import.
This GitHub catalog imports the case from the verified Hugging Face snapshot. The session export is referenced through that fixed revision; the cover and introduction are stored in this repository.
Case files
Run this kind of analysis on your own question
Start a session and see how an AI co-scientist accelerates your research. Pay-as-you-go, nosubscription required.



